SEBI reviewing regulation restricting business activities of AMCs


Logo of Securities and Exchange Board of India (SEBI). File

Logo of Securities and Exchange Board of India (SEBI). File
| Photo Credit: Reuters

The Securities and Exchange Board of India (SEBI) is reviewing the mutual fund regulations that place restrictions on the business activities of asset management companies (AMC), said executive director Manoj Kumar.

“We are doing a significant review of regulation 24. This is the only restrictive clause under the mutual fund regulation,” Mr. Kumar said at the CII Mutual Fund Summit here on Tuesday.

Clause 24 of the mutual fund regulation deals with the issues pertaining to business activities that AMCs can take. The regulation mandates AMCs not to undertake business activities that are in conflict of interest with the core business of managing mutual fund schemes.

It mandates SEBI’s approval to advise or provide consultancy to foreign funds. It also makes sure the bank and securities accounts are maintained separately and there are separate fund managers for different funds.

Mutual fund companies say that this makes it difficult for them to expand into different businesses and a relaxation would help them to step into more lucrative avenues.

“We are also trying to review the entire regulation because we have come to notice that mutual fund regulation is the lengthiest regulation, so that calls for a comprehensive review,” Mr. Kumar added.

The approach to regulation in SEBI has changed after the new chief Tuhin Kanta Pandey took office. “We are moving from key regulatory areas (KRAs)-based system, which has definitely delivered, to a conducive regulatory approach, where we will try to create an environment where we as a regulator work together with the industry,” Mr. Kumar said. The statement assumes significance as Mr. Pandey had underlined the approach of SEBI under his leadership to be of an optimum regulation rather than maximum regulation.



Source link

  • Related Posts

    Lupin, China’s SUP ink pact for COPD drug Tiotropium DPI

    Lupin has signed a license and supply agreement with Sino Universal Pharmaceuticals (SUP) for commercialisation of chronic obstructive pulmonary disease drug Tiotropium Dry Powder Inhaler, 18 mcg/capsule, in the Chinese…

    Continue reading
    India to export 150 locomotives to Africa worth over ₹3,000 crore

    “These locomotives are fitted with Distributed Power Wireless Control System, or DPWCS, for synchronised operations and superior freight handling,” a Railways Ministry spokesperson said. Photo: https://www.wabteccorp.com/ India will supply 150…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *